Hartalega (5168) Q3 2026 earnings summary

Executive summary

• Q3 FY2026 revenue was RM527 million, down 2% sequentially and 29% year-over-year, mainly due to lower ASP from a stronger MYR and pricing pressure, despite a 3% increase in sales volume to 6.2 billion pieces.

• Profit after tax rose 78% quarter-over-quarter and 64.1% year-over-year to RM32 million, reflecting robust cost optimization and automation benefits.

• EBITDA increased to RM70 million (13% margin), supported by improved production efficiencies and higher plant utilization.

• For the nine months ended 31 December 2025, revenue was RM1.62 billion, down 17.9% year-over-year, but operating profit increased 32.5% to RM57.7 million.

• Operating profit for Q3 FY2026 increased to RM36.3 million, supported by cost optimisation and efficiency gains.

Financial highlights

• Q3 FY2026 operating profit: RM36.3 million (Q3 FY2025: RM35.7 million), with OP margin up 4.2 points to 7%.

• Q3 FY2026 net profit: RM31.7 million (Q3 FY2025: RM19.3 million).

• 9M FY2026 revenue: RM1.62 billion (9M FY2025: RM1.97 billion).

• Earnings per share for Q3 FY2026: 0.93 sen (Q3 FY2025: 0.57 sen).

• Strong net cash position of approximately RM1.1 billion as of end-December 2025.

Outlook and guidance

• Glove demand expected to rise in 1H CY2026, driven by global healthcare consumption and hygiene awareness.

• Long-term industry prospects remain positive due to higher hygiene awareness and healthcare access, with structural glove demand projected to grow at around 6% annually.

• Near-term challenges include global overcapacity, intense price competition, and cost pressures, especially from Chinese manufacturers.

• Ongoing investments in automation, technology, and ESG initiatives are expected to support competitiveness and margin resilience.

• Plant 9 to be fully commissioned by March 2026, enhancing automation and production efficiency.